Weng Shiwen

1PUBLICATIONS
1CO-AUTHORS
Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 10, 2024
A randomized, double-blind, placebo-controlled, dose-escalating phase IIa trial to evaluate the safety, tolerability, efficacy, and pharmacokinetics of multiple oral doses of Pynegabine tablets as add-on therapy in patients with focal epilepsy.

Shan Wei, Weng Shiwen, Chang Cao-Wenjing

Pageof 1

Frequent Collaborators

1 joint publications

Wang Qun